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Proteins are now widely produced in diverse microbial cell factories. The Escherichia coli
is still the dominant host for recombinant protein production but, as a bacterial cell, it
also has its issues: the aggregation of foreign proteins into insoluble inclusion bodies
is perhaps the main limiting factor of the E. coli expression system. Conversely, E. coli
beneﬁts of cost, ease of use and scale make it essential to design new approaches
directed for improved recombinant protein production in this host cell. With the aid of
genetic and protein engineering novel tailored-made strategies can be designed to suit
user or process requirements. Gene fusion technology has been widely used for the
improvement of soluble protein production and/or puriﬁcation in E. coli, and for increasing
peptide’s immunogenicity as well. New fusion partners are constantly emerging and
complementing the traditional solutions, as for instance, the Fh8 fusion tag that has been
recently studied and ranked among the best solubility enhancer partners. In this review, we
provide an overview of current strategies to improve recombinant protein production in E.
coli, including the key factors for successful protein production, highlighting soluble protein
production, and a comprehensive summary of the latest available and traditionally used
gene fusion technologies. A special emphasis is given to the recently discovered Fh8 fusion
system that can be used for soluble protein production, puriﬁcation, and immunogenicity in
E. coli. The number of existing fusion tags will probably increase in the next few years, and
efforts should be taken to better understand how fusion tags act in E. coli. This knowledge
will undoubtedly drive the development of new tailored-made tools for protein production
in this bacterial system.
Keywords: Escherichia coli, fusion tags, soluble production, protein purification, tag removal, Fh8 tag, H tag, protein
immunogenicity
OUTLINE
Proteins are key elements of life, constituting the major part of the
living cell. They play important roles in a variety of cell processes,
including cell signaling, immune responses, cell adhesion, and the
cell cycle, and their failure is consequently correlated with several
diseases.
With the introduction of the DNA recombinant technology in
the 1970s, proteins started to be expressed in several host organ-
isms resulting in a faster and easier process compared to their
natural sources (Demain and Vaishnav, 2009). Escherichia coli
remains the dominant host for producing recombinant proteins,
owing to its advantageous fast and inexpensive, and high yield
protein production, together with the well-characterized genetics
and variety of available molecular tools (Demain and Vaishnav,
2009).
The recombinant protein production in E. coli has greatly con-
tributed for several structural studies; for instance, about 90% of
the structures available in the Protein Data Bank were determined
onproteins produced inE. coli. (Nettleship et al., 2010; Bird, 2011).
The E. coli recombinant production has also boosted the biophar-
maceutical industry: 30% of the recombinant biopharmaceuticals
licensed up to 2011 by the U.S. Food and Drug Administration
(FDA) and European Medicines Agency (EMEA) were obtained
using this host cell (Ferrer-Miralles et al., 2009;Walsh, 2010; Berlec
and Strukelj, 2013).
Escherichia coli recombinant protein-based products can also
be found in major sectors of the enzyme industry and the agri-
cultural industry with applications ranging from catalysis (e.g.,
washing detergents) and therapeutic use (e.g., vaccine develop-
ment) to functional analysis and structure determination (e.g.,
crystallography; Demain and Vaishnav, 2009).
As a bacterial system, the E. coli has, however, limitations at
expressing more complex proteins due to the lack of sophisticated
machinery to perform posttranslational modiﬁcations, resulting
in poor solubility of the protein of interest that are produced as
inclusion bodies (Demain and Vaishnav, 2009; Kamionka, 2011).
Previous studies (Bussow et al., 2005; Pacheco et al., 2012) reported
that up to 75% of human proteins are successfully expressed in E.
coli but only 25% are produced in an active soluble form using
this host system. Other problems found within this host system
include proper formation of disulﬁde bonds, absence of chap-
erones for the correct folding, and the miss-match between the
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codon usage of the host cell and the protein of interest (Terpe,
2006; Demain and Vaishnav, 2009; Pacheco et al., 2012). More-
over, the industrial culture of E. coli leads cells to grow in harsh
conditions, resulting in cell physiology deterioration (Chou, 2007;
Pacheco et al., 2012).
Despite the above-mentioned issues of E. coli recombinant pro-
tein production, the beneﬁts of cost and ease of use and scale make
it essential to design new strategies directed for recombinant sol-
uble protein production in this host cell. Several strategies have
been made for efﬁcient production of proteins in E. coli, namely,
the use of different mutated host strains, co-production of chaper-
ones and foldases, lowering cultivation temperatures, and addition
of a fusion partner (Terpe, 2006; Demain andVaishnav, 2009). The
combination of some of these strategies has improved the soluble
production of recombinant proteins in E. coli, but the prediction
of robust soluble protein production processes is still a“a challenge
and a necessity” (Jana and Deb, 2005).
Nowadays, with the aid of genetic and protein engineering,
novel tailor-made strategies can be designed to suit user or process
requirements.
This review describes the key solubility factors that correlate
with successful protein production in E. coli, and it presents a
comprehensive summary of the available fusion partners for pro-
tein production and puriﬁcation in the bacterial host. A main
focus is given to the novel Fh8 fusion system (Hitag®) for soluble
protein production, puriﬁcation and immunogenicity in E. coli
(Costa, 2013).
SOLUBLE PROTEIN PRODUCTION IN ESCHERICHIA COLI
The production of recombinant proteins requires a successful cor-
relation between the gene’s expression, protein solubility, and its
puriﬁcation (Esposito and Chatterjee, 2006). The production lev-
els of recombinant proteins synthesized in E. coli are no longer
pointed as a limitation for the success of the overall process, but
care should be taken with the protein solubility, which is still
a major bottleneck in the ﬁeld. The downstream processing is
deeply associated with an efﬁcient protein production strategy,
and thus it must be tailor-designed to maximize the recovery of
pure recombinant proteins.
All these three properties – expression, solubility, and puriﬁca-
tion – shall always be considered together as determinants for the
effective protein production in E. coli. Several aspects are though
essential for each individual success, as resumed in Figure 1 and
described.
STRATEGIES FOR THE SUCCESSFUL AND EFFICIENT SOLUBLE PROTEIN
PRODUCTION IN E. COLI – PREVENTION OF PROTEIN AGGREGATION
Escherichia coli recombinant protein production systems are
designed to achieve a high accumulation of soluble protein prod-
uct in the bacterial cell. However, a strong and rapid protein
production can lead to stressful situations for the host cell, result-
ing in protein misfolding in vivo, and consequent aggregation into
inclusion bodies (Schumann and Ferreira, 2004; Sorensen and
Mortensen, 2005a,b; Sevastsyanovich et al., 2010). For instance,
macromolecular crowding of proteins at high concentrations in
the E. coli cytoplasm often impairs the correct folding of pro-
teins, leading to the formation of folding intermediates that,
when inefﬁciently processed by molecular chaperones, promote
inclusion body formation (Sorensen and Mortensen, 2005a,b).
Strategies that direct the soluble production of proteins in E.
coli are, thus, envisaged, and become more attractive than protein
refolding procedures from inclusion bodies.
Several methods have been shown to prevent or decrease
protein aggregation during protein production in E. coli on a
trial-and-error basis, including:
(i) Lower expression temperatures: bacteria cultivation at reduced
temperatures is often used to reduce protein aggregation, since
it slows down the rate of protein synthesis and folding kinet-
ics, decreasing the hydrophobic interactions that are involved
in protein self-aggregation (Schumann and Ferreira, 2004;
Sorensen and Mortensen, 2005b). Low cultivation tempera-
tures can also reduce or impair protein degradation due to a
poor activity of heat shock proteases that are usually induced
during protein overproduction in E. coli (Chesshyre and Hip-
kiss, 1989). This strategy has, however, some drawbacks
as the reduction of temperature can also affect replication,
transcription, and translation rates, besides decreasing the
bacterial growth and protein production yields. Nevertheless,
these limitations can be circumvented by the use of cold-
inducible promoters that maximize protein production under
low temperature conditions (Mujacic et al., 1999).
(ii) E. coli-engineered host strains: E. coli mutant strains are a
signiﬁcant advance toward the soluble production of difﬁcult
recombinant proteins. Several targeted strain strategies have
been developed through the introduction of DNA mutations
that affect protein synthesis, degradation, secretion, or fold-
ing (reviewed in Makino et al., 2011), including: engineered
strains for improved protein processing at low tempera-
tures, such as the Arctic Express strain (Agilent Technologies);
mutated strains that increase mRNA stability by attenuation
of RNases activity, which is responsible for the shorter half-
life of mRNA in E. coli cells (Lopez et al., 1999); engineered
strains that supply extra copies of rare tRNAs, such as the
Rosetta strains (Invitrogen) and the BL21 Codon Plus strains
(Novagen; Baca andHol, 2000; Sorensen et al., 2003b); mutant
strains that facilitate disulﬁde bond formation and protein
folding in the E. coli cytoplasm by render it oxidizing due
to mutations in glutathione reductase (gor) and thioredoxin
reductase (trxB) genes, and/or by co-production of Dsb pro-
teins (Bessette et al., 1999; Lobstein et al., 2012), such as the
Origami strains (Novagen) or the new SHufﬂe strain (New
England Biolabs; Lobstein et al., 2012); and C41 and C43
(Avidis) BL21 (DE3)mutant strains that improve the synthesis
of membrane proteins (Miroux and Walker, 1996).
(iii) Cultivation conditions: protein production can be efﬁciently
improved by the use of high cell-density culture systems like
batch, which offers a limited control of the cell growth, and
fed-batch, which allows the real time optimization of growth
conditions (Sorensen and Mortensen, 2005b). The composi-
tion of the cell growthmedium and the fermentation variables
such as temperature, pH, induction time, and inducer con-
centration are also essential for the prevention of protein
aggregation, whereby a careful optimization improves the
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FIGURE 1 | Strategies for soluble protein production in E. coli.
(A) Expression vectors should be carefully selected in order to
incorporate speciﬁc features that affect the protein production in E.
coli such as solubility and/or afﬁnity fusion tags, and to direct the
protein synthesis to the E. coli cytoplasm or periplasm. Other
important features include: the replicon, antibiotic-resistance markers,
and transcriptional promoters (Jana and Deb, 2005; Sorensen and
Mortensen, 2005a). (B) The optimization of expression conditions often
directs the soluble protein production in E. coli, and it relies on a
trial-and-error basis: to get a soluble TP, it may require the selection
and testing of several engineered E. coli strains and cultivation
conditions, and sometimes the initial expression vector has also to be
re-designed. (C) The protein puriﬁcation strategy should already be
deﬁned at the beginning when selecting the expression vector: if an
afﬁnity tag is incorporated, then a ﬁrst afﬁnity chromatography step
should be conducted. On the other hand, if an afﬁnity tag is prohibit,
other strategies, namely, ion exchange, size exclusion, or hydrophobic
interaction chromatography should be tested. After the ﬁrst puriﬁcation
step, the TP may or may not be sufﬁciently pure. When it is not
pure, further puriﬁcation steps with other chromatographic strategies
need to be conducted. (D–E) The protein quality is an essential
requirement for many structural and functional application studies: a
puriﬁed soluble protein may be aggregated, without a deﬁned
secondary structure, and it may also present a low thermal stability.
Therefore, a biophysical characterization is often required before
proceeding to the ﬁnal protein’s application.
yield and quality of soluble protein production (Jana and Deb,
2005).
(iv) Co-production of molecular chaperones and folding modulators:
the initial folding of proteins can be assisted by molecular
chaperones that prevent protein aggregation through binding
exposed hydrophobic patches on unfolded, partially folded
or misfolded polypeptides, and trafﬁc molecules to their sub-
cellular destination. Protein aggregation is also prevented by
folding catalysts that catalyze important events in protein fold-
ing such as the disulﬁde bond formation (Kolaj et al., 2009). A
low concentration of these folding modulators in the cell often
results in protein folding failures; thereby their co-production
together with the target protein becomes a suitable strategy
for the improvement of soluble protein production in E. coli
(reviewed in Thomas et al., 1997; Schlieker et al., 2002; Baneyx
and Palumbo, 2003; Hoffmann and Rinas, 2004; Betiku,
2006; Gasser et al., 2008; Kolaj et al., 2009). Chaperones like
trigger factor, DnaK, GroEL, members of the heat shock pro-
tein Hsp70 and Hsp60 families (hsHsp proteins), and ClpB
assist protein folding in the E. coli cytoplasm, and their
individual or cooperative activities presents different contri-
butions for target protein solubility (Nishihara et al., 1998;
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Kuczynska-Wisnik et al., 2002; Schlieker et al., 2002; Deuer-
ling et al., 2003; de Marco and De Marco, 2004; de Marco
et al., 2007).
(v) Fusion partner proteins: in contrast to the above-mentioned
strategies, the use of fusion partners involves the target pro-
tein engineering. Fusion partners are very stable peptide or
protein molecules soluble expressed in E. coli that are geneti-
cally linked with target proteins to mediate their solubility and
puriﬁcation.
CHROMATOGRAPHIC STRATEGIES FOR RECOMBINANT PROTEIN
PURIFICATION
The protein puriﬁcation accounts for most of the expenses in
recombinant protein production. Hence, the design of a straight-
forward and cost-effective protein isolation and puriﬁcation is one
of the ﬁrst steps to be considered in the production strategy.
There is no single or simple way to purify all kinds of
proteins because of their diversity and different properties.
Therefore, several strategies have been developed in the past
decades to address a broad range of samples. With the intro-
duction of recombinant DNA technology in the seventies,
novel afﬁnity tagging methodologies have revolutionized pro-
tein puriﬁcation processes and several easy-to-use afﬁnity tags
have emerged since then. Besides the isolation of recombinant
proteins, the puriﬁcation process is also used to concentrate
the desired protein. The target protein is usually ﬁrst designed
to be afﬁnity tagged, thus facilitating the puriﬁcation pro-
cess and allowing the target protein to maintain its properties
without interacting directly with a matrix. However, if the
target protein cannot be afﬁnity tagged or if further puriﬁca-
tion is needed, other puriﬁcation strategies are added to the
process.
When designing a puriﬁcation strategy, one must consider
the ﬁnal goal of the target protein to be puriﬁed. For instance,
recombinant proteins for therapeutic and biomedical applications
require a high-level of protein purity and they probably should
undergo several subsequent puriﬁcation steps.
The available protein puriﬁcation methodologies separate the
target proteins according to differences between the proper-
ties of the protein to be puriﬁed and properties of the rest
of the protein mixture. Recombinant proteins are nowadays
puriﬁed using column chromatography in scales from micro-
grams or milligrams in research laboratories to kilograms in
industrial settings. The puriﬁcation of a target protein from a
crude cell extract is, however, not always easy and even with
all the progresses achieved so far, additional physicochemical-
based chromatography methods such as size exclusion (SEC), ion
exchange (IEX), and hydrophobic interaction (HIC) are often
used to complement the afﬁnity tagging. These methods rely
on minor differences between various proteins properties such
as size, charge, and hydrophobicity, respectively (GE Healthcare,
2010).
In a traditional puriﬁcationpipeline, the chromatography starts
with a capturing step, where the target protein binds to the
absorbent while the impurities do not. Then, weakly bound pro-
teins are washed out of the column, and conditions are changed
so that the target protein is eluted from the column.
Size exclusion chromatography
This technique is a non-binding method that separates protein
samples with different molecular sizes under mild conditions.
Size exclusion chromatography (SEC) can be used for protein
puriﬁcation, in which it usually dilutes the sample, or for group
separation, which is mainly used for desalting and buffer exchange
of samples. This technique is ideal for the ﬁnal polishing in
a multiple-step puriﬁcation strategy. Analytical SEC allows the
determination of the hydrodynamic radius of protein molecules
and the corresponding molecular weight (GE Healthcare, 2010).
Ion exchange chromatography
This technique separates proteinswith different surface charge and
it offers a high-resolution separation combined with high sample
loading capacity. The puriﬁcation relies on a reversible interaction
between a charged protein and an oppositely charged chromatog-
raphymedium. Proteins puriﬁedby ion exchange chromatography
(IEX) are usually obtained in a concentrated form. The net sur-
face charge of proteins is inﬂuenced by the surrounding pH: when
the pH is above the protein isoelectric point (pI), the target pro-
tein has a negatively charged shield that is used for binding to
a positively charged anion exchanger; when the pH is below its
pI, the target protein has a positively charged shield that is used
for binding to a negatively charged cation exchanger. The IEX
puriﬁcation protocol is initiated under low ionic strength, and
the conditions are then changed so that the bound substances
can be eluted differentially by increasing salt concentration or
changing pH using a gradient or stepwise strategy. In general,
the IEX is used to bind the target protein, but it can also be used
to bind impurities when required. The IEX is the most common
technique used for the capture step in a multiple-step puriﬁca-
tion strategy, but it can be used in the intermediate step as well
(GE Healthcare, 2010).
Hydrophobic interaction chromatography
Hydrophobic interaction chromatography (HIC) separates pro-
teins according to differences in their surface hydrophobicity by
using a reversible interaction between non-polar regions on the
surface of these proteins and the immobilized hydrophobic ligands
of aHICmedium (Queiroz et al., 2001). The proteins are separated
according to differences in the amount of exposed hydrophobic
amino acids. This technique is ideal for capture and intermediate
steps in a multiple-step puriﬁcation strategy.
The interaction between hydrophobic proteins and a HIC
medium is inﬂuenced signiﬁcantly by several parameters
(reviewed in Queiroz et al., 2001; Lienqueo et al., 2007), including:
(i) The type of the ligand and degree of substitution: the type
of immobilized ligand (alkyl or aryl) determines the pro-
tein adsorption selectivity of the HIC adsorbent. In general,
alkyl ligands show more pure hydrophobic character than aryl
ligands. The protein binding capacities of HIC adsorbents
increase with increased degree of substitution of immo-
bilized ligand. The degree of substitution is the average
number of substituent groups attached per milliliter of gel,
and it correlates with the protein binding capacities of HIC
adsorbents as follows: higher binding capacities are obtained
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with an increased degree of substitution of immobilized lig-
and. At a reasonably high degree of ligand substitution,
the apparent binding capacity of the adsorbent remains
constant (the plateau is reached) but the strength of the inter-
action increases. Solutes bound under such circumstances
are difﬁcult to elute due to multi-point attachment (GE
Healthcare, 2006).
(ii) The type of base matrix: the matrix should be neutral to avoid
ionic interactions between the protein and the matrix, and it
should also be hydrophilic. The twomostwidely usedmatrices
are strongly hydrophilic carbohydrates, such as cross-linked
agarose, or synthetic copolymer materials (GE Healthcare,
2006).
(iii) The type and concentration of salt : a high salt concen-
tration enhances the interaction, while lowering the salt
concentration weakens the interaction. The effect of the
salt type on protein retention follows the Hofmeister series
for the precipitation of proteins from aqueous solutions
(Collins and Washabaugh, 1985; Zhang and Cremer, 2006).
In Hofmeister series, the chaotropic salts (magnesium sul-
fate and magnesium chloride) randomize the structure of
the liquid water and thus tend to decrease the strength
of hydrophobic interactions. In contrast, the kosmotropic
salts (sodium, potassium, or ammonium sulfates) promote
hydrophobic interactions and protein precipitation, due to
higher “salting-out” or molar surface tension increment
effects.
(iv) pH : when pH is close to a protein’s pI, net charge is zero
and hydrophobic interactions are maximum, due to the min-
imum electrostatic repulsion between the protein molecules
allowing them to get closer. In general, an increase in the
pH weakens the hydrophobic interaction probably due to an
increased titration of charged groups, thereby leading to an
increase of protein hydrophilicity. A decrease of the pH may
result in an increase of hydrophobic interactions. However,
the effect of pH in HIC is not always straightforward (GE
Healthcare, 2006).
(v) Temperature: the role of temperature in HIC is complex,
but in general, increased temperatures enhance the protein
retention. Careful should be taken when conducting protein
puriﬁcations at room temperature as the protein performance
in the HIC will probably not be reproducible in a cold room,
and vice versa.
(vi) Additives: low concentrations of water-miscible alcohols,
detergents, and aqueous solutions of chaotropic (“salting-in”)
salts result in a weakening of the protein–ligand interactions
in HIC leading to the desorption of the bound solutes. The
non-polar parts of alcohols and detergents compete with the
bound proteins for the adsorption sites on the HIC media
resulting in the displacement of the latter. Chaotropic salts
affect the ordered structure of water and/or that of the bound
proteins. Both types of additives also decrease the surface ten-
sion of water thus weakening the hydrophobic interactions to
give a subsequent dissociation of the ligand–solute complex.
The use of additives should be carefully considered as they
might compromise the target protein structure and activity
(GE Healthcare, 2006, 2010).
Proteins bound to HIC media can be eluted using some of the
above-mentioned conditions such as reduced salt concentration,
increasedpH,or additionof alcohols or detergents (Lienqueo et al.,
2007), but trial-and-error experiments should be conducted to
select the best option for each speciﬁc target protein.
Besides protein puriﬁcation, the HIC methodology offers sev-
eral potentialities in protein production, being described as one
of the most used strategies for endotoxin clearance (Wilson et al.,
2001; Magalhães et al., 2007; Ongkudon et al., 2012). It can also be
used for protein refolding (Hwang et al., 2010).
The HIC methodology has been applied for the puriﬁcation
of calcium-binding proteins (CaBPs; Rozanas, 1998; Shimizu
et al., 2003; McCluskey et al., 2007). These proteins expose a large
hydrophobic surface in the presence of calcium that can absorb to
hydrophobic matrices such as phenyl sepharose, even in the pres-
ence of low salt concentration. Most of the contaminant proteins
will not bind under these conditions, which beneﬁts the recovery
of a pure CaBP. The elution step is often achieved by removal of
the bound calcium through the use of chelating agents like EDTA
(Rozanas, 1998).
Afﬁnity chromatography
This technique separates proteins through a reversible interac-
tion between the target protein and a speciﬁc ligand attached to a
chromatographic matrix. The interaction can be performed via an
antibody (biospeciﬁc interaction), or via an immobilizedmetal ion
(non-biospeciﬁc interaction) or dye substance. The afﬁnity chro-
matography usually offers high selectivity and resolution together
with an intermediate-high capacity. The sample is ﬁrst bound to
the ligand using favorable conditions for that binding. Then, the
unbound material is washed out of the column and the elution of
pure protein is achieved using a competitive ligand or by chang-
ing the pH, ionic strength or polarity (GE Healthcare, 2010). This
puriﬁcation strategy can proﬁt from the use of recombinant DNA
technology as the afﬁnity tag can be fused to the protein of interest
during cloning and it is further presented in the next section.
FUSION PROTEIN TECHNOLOGY
Fusion partners or tags are used in E. coli to improve pro-
tein production yields, solubility and folding, and to facilitate
protein puriﬁcation. They can also confer speciﬁc properties
for target proteins characterization and study, such as protein
immunodetection, quantiﬁcation, and structural and interac-
tional studies (Malhotra, 2009). Fusion partners can also be of
use when producing toxic proteins. An example is the production
of antimicrobial peptides (AMPs) by E. coli using cellulose bind-
ing modules as fusion partner (Guerreiro et al., 2008; Ramos et al.,
2010, 2013). The use of carbohydrate-binding modules (CBMs)
as fusion partner has also been applied for targeting peptides
and/or functionalizing speciﬁc supports/biomaterials for biomed-
ical applications (Moreira et al., 2008; Andrade et al., 2010a,b;
Pértile et al., 2012). Besides the fusion(s) partner(s) coding gene,E.
coli expression vectors can contain a protease recognition sequence
between the fusion partner coding gene and the passenger protein
coding gene that allows the tag removal when the latter protein is
for using in protein therapies, vaccine development and structural
analyses.
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Some fusion partners also protect target proteins from degra-
dation by promoting the translocation of the passenger protein
to different cellular locations, where less protease content exists
(Butt et al., 2005). Both maltose-binding protein (MBP) and small
ubiquitin related modiﬁer (SUMO) fusion partners present this
feature, passing target proteins from the E. coli cytosol for cell
membrane and nucleus, respectively (Nikaido, 1994; Kishi et al.,
2003).
When designing a fusion strategy, the choice of the fusion
partner depends on several aspects (Young et al., 2012), including:
(i) Purpose of the fusion: is it for solubility improvement or for
afﬁnity puriﬁcation? Nowadays, a variety of fusion tags that
render different purposes are available, and systems contain-
ing both solubility and afﬁnity tags like, for instance, the
dual hexahistine (His6)-MBP tag, can be designed in order
to get a rapid “in one step” protein production. Some pro-
tein tags can also function in both afﬁnity and solubility
roles, as for instance, the MBP or glutathione-S-transferase
(GST; Esposito and Chatterjee, 2006). If the fusion tag is to
be used in protein puriﬁcation, the cost and buffer conditions
are often the criteria for selection. For instance, proteins that
require chelating agents as EDTA are not suitable for immo-
bilized metal afﬁnity chromatography (IMAC) via the His6
tag as nickel ions in the afﬁnity matrix are chelated by EDTA
(Malhotra, 2009).
(ii) Amino acid composition and size: these two factors should
be considered when selecting a fusion partner because tar-
get proteins may require larger or smaller tags depending on
their application. Larger tags can present a major diversity
in the amino acid content, and will impose a metabolic bur-
den in the host cell different from that imposed by small tags
(Malhotra, 2009).
(iii) Required production levels: structural studies require higher
protein production levels that can be rapidly achieved with a
larger fusion tag, which has strong translational initiation sig-
nals, whereas the study of physiological interactions demands
for lower production levels and small tags (Malhotra, 2009).
(iv) Tag location: fusion partners can promote different effects
when located at the N-terminus or C-terminus of the passen-
ger protein. Usually, N-terminal tags are advantageous over
C-terminal tags because: (1) they provide a reliable context for
efﬁcient translation initiation, in which fusion proteins take
advantage of efﬁcient translation initiation sites on the tag; (2)
they can be removed leaving none or few additional residues
at the native N-terminal sequence of the target protein, since
most of endoproteases cleave at or near the C-terminus of
their recognition sites (Waugh, 2005; Malhotra, 2009).
Fusion tags can be incorporated using different strategies: afﬁn-
ity and solubility tags are set individually or together, and sites for
protease cleavage are designed between the fusion tags and target
proteins.
Solubility enhancer partners
In spite of all the approaches conducted so far, the choice of a
fusion partner is still a trial-and-error experience. Fusion part-
ners do not perform equally with all target proteins, and each
target protein can be differentially affected by several fusion tags
(Esposito and Chatterjee, 2006). In the past decade, parallel high
throughput (HTP) screenings using different fusion partners have
developed soluble protein production, and facilitated a rapid,
tailored, and cost-effective choice of the best fusion partner for
each target protein (Hammarstrom et al., 2002; Shih et al., 2002;
Dyson et al., 2004; Dummler et al., 2005; Cabrita et al., 2006; Ham-
marstrom, 2006; Marblestone et al., 2006; Kim and Lee, 2008; Kohl
et al., 2008; Ohana et al., 2009; Bird, 2011).
The mechanisms by which fusion tags enhance the solubility of
their partner proteins remain unclear, but several hypotheses have
been suggested (Butt et al., 2005; Nallamsetty and Waugh, 2007):
(i) Fusion proteins form micelle-like structures: misfolded or
unfolded proteins are sequestered and protected from the
solvent and the soluble protein domains face outward;
(ii) Fusion partners attract chaperones: the fusion tag drives its
partner protein into a chaperone-mediated folding pathway.
MBP and N-utilization substance (NusA) are two fusion tags
that present this mechanism, being previously reported to
interact with GroEL in E. coli (Huang and Chuang, 1999;
Douette et al., 2005);
(iii) Fusion partners have an intrinsic chaperone-like activity:
hydrophobic patches of the fusion tag interact with partially
folded passenger proteins, preventing their self-aggregation,
and promoting their proper folding. MBP was previously
reported to act also as a chaperone in the fusion con-
text (Kapust and Waugh, 1999; Fox et al., 2001). Solubility
enhancer partners may thus play a passive role in the fold-
ing of their target proteins, reducing the chances for protein
aggregation (Waugh, 2005; Nallamsetty and Waugh, 2006);
(iv) Fusion partners net charges: highly acidic fusion partners
were suggested to inhibit protein aggregation by electrostatic
repulsion (Zhang et al., 2004; Su et al., 2007).
A large variety of solubility enhancer tags are available (Table 1),
including the well-known MBP, NusA, thioredoxin (TrxA), GST,
and SUMO, and several other novel moieties recently discovered,
for instance, the Fh8 tag.
MBP is a large (43 kDa) periplasmic and highly soluble protein
of E. coli that acts as a solubility enhancer tag (Kapust and Waugh,
1999; Fox et al., 2001), and it has a native afﬁnity property to
function as a puriﬁcation handle.
MBP plays an important role in the translocation of maltose
and maltodextrins (Nikaido, 1994): it has a natural protein-
binding site that it uses to interact with other proteins involved
in maltose signaling and chemotaxis, and it has a large hydropho-
bic cleft close to this site that undergoes conformational changes
upon maltose binding (Fox et al., 2001).
When used in the fusion context, MBP promotes target pro-
tein solubility by showing chaperone intrinsic activity (Kapust and
Waugh, 1999; Bach et al., 2001; Fox et al., 2001), and it is more efﬁ-
cient at the N-terminus of the target proteins rather than at the
C-terminus (Sachdev andChirgwin, 2000). In fact,MBPpromotes
the proper folding of the target protein by interacting with the lat-
ter, and occluding its self-association. This passive role of MBP
in protein folding is correlated with the large hydrophobic area
exposed on its surface, which is responsible for the contact with
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Table 1 | Solubility enhancer tags [adapted from Esposito and Chatterjee (2006), Malhotra (2009)].
Tag Protein Size (aa) Organism Reference
Fh8 Fasciola hepatica 8-kDa antigen 69 F. hepatica Costa (2013), Costa et al. (2013a,b)
MBP Maltose-binding protein 396 Escherichia coli di Guan et al. (1988),
Kapust andWaugh (1999)
NusA N-utilization substance 495 E. coli Davis et al. (1999)
Trx Thioredoxin 109 E. coli Lavallie et al. (1993)
SUMO Small ubiquitin modiﬁed ∼100 Homo sapiens Butt et al. (2005), Marblestone et al. (2006)
GST Glutathione-S-transferase 211 Schistosoma japonicum Smith and Johnson (1988)
SET Solubility-enhancer peptide sequences <20 Synthetic Zhang et al. (2004)
GB1 IgG domain B1 of Protein G 56 Streptococcus sp. Zhou et al. (2001), Cheng and Patel (2004)
ZZ IgG repeat domain ZZ of Protein A 116 Staphylococcus aureus Rondahl et al. (1992), Inouye and Sahara
(2009)
HaloTag Mutated dehalogenase ∼300 Rhodococcus sp. Ohana et al. (2009)
SNUT Solubility eNhancing UbiquitousT ag 147 Staphylococcus aureus Caswell et al. (2010)
Skp Seventeen kilodalton protein 161 E. coli Esposito and Chatterjee (2006)
T7PK PhageT7 protein kinase ∼240 BacteriophageT7 Esposito and Chatterjee (2006)
EspA E. coli secreted protein A 192 E. coli Cheng et al. (2010)
Mocr Monomeric bacteriophageT7 0.3
protein (Orc protein)
117 BacteriophageT7 DelProposto et al. (2009)
Ecotin E. coli trypsin inhibitor 162 E. coli Malik et al. (2006, 2007)
CaBP Calcium-binding protein 134 Entamoeba histolytica Reddi et al. (2002)
ArsC Stress-responsive arsenate reductase 141 E. coli Song et al. (2011)
IF2-domain I N-terminal fragment of translation
initiation factor IF2
158 E. coli Sorensen et al. (2003a)
Expressivity tag
(part of IF2-domain I)
N-terminal fragment of translation
initiation factor IF2
7 (21 nt) E. coli Hansted et al. (2011)
RpoA, SlyD, Tsf,
RpoS, PotD, Crr
Stress-responsive proteins 329, 196, 283,
330, 348, 169
E. coli Ahn et al. (2007), Han et al. (2007a,b,c),
Park et al. (2008)
msyB, yjgD, rpoD E. coli acidic proteins 124, 138, 613 E. coli Su et al. (2007), Zou et al. (2008)
aa– amino acids; nt– nucleotides.
other proteins in the maltose transport apparatus (Kapust and
Waugh, 1999; Fox et al., 2001). Hence, the MBP hydrophobic cleft
is pointed as the site where fused polypeptides interact with the
fusion partner (Kapust and Waugh, 1999; Fox et al., 2001; Nallam-
setty and Waugh, 2007), similar to what it is reported for GroEL
and DnaK molecular chaperones (Buckle et al., 1997; Chatellier
et al., 1999; Tanaka and Fersht, 1999). The presence of this cleft
can explain why only certain soluble proteins like MBP act as sol-
ubilizing agents. Moreover, MBP presents certain conformational
ﬂexibility associated with the cleft; thereby it can adjust its shape
to accommodate several different polypeptides.
MBP fusion proteins bind to immobilized amylose resins, but
this binding is highly dependent on the nature of the passenger
protein as it can block or reduce the amylose interaction (Pryor
and Leiting, 1997). Difﬁculties found in the binding of MBP fusion
proteins to amylose resins corroborate the hypothesis that tar-
get proteins interact with MBP via its binding site (Fox et al.,
2001).
Other afﬁnity tags, speciﬁc proteases and protein cultivation
strategies are being employed together with MBP to improve pro-
tein soluble production, puriﬁcation and native protein recovery,
as for instance, His6-MBP fusions (Nallamsetty et al., 2005), His6-
MBP-TEV fusions (Rocco et al., 2008), MBP-His6-Smt3 fusions in
which the Saccharomyces cerevisiae Smt3 protein is used for pro-
tein processing by proteolytic cleavage between the MBP-His6 tags
and the protein of interest (Motejadded and Altenbuchner, 2009),
and secretion of MBP fusion protein into the culture medium
(Sommer et al., 2009).
Several commercial expression vectors containing the MBP tag
are available for cytoplasmic and periplasmic production of target
proteins, including the pMAL series (New England Biolabs) and
pIVEX (Roche).
NusA is a transcription termination/anti-termination protein
that promotes/prevents RNA polymerase pausing when acting
alone or when included in the anti-termination complex, respec-
tively. NusA (55 kDa) is used as a fusion partner to confer
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stability and high solubility to its target proteins (De Marco et al.,
2004; Dummler et al., 2005; Turner et al., 2005). The NusA abil-
ity to improve the soluble production of fusion proteins may be
correlated with its intrinsically solubility and biological activity
in E. coli. NusA slows down translation at the transcriptional
pauses, offering more time for protein folding (Davis et al., 1999;
De Marco et al., 2004). In contrast to MBP, NusA does not present
an intrinsic afﬁnity property, therefore requiring the addition of
an afﬁnity tag for efﬁcient protein production, as for instance,
the His6 tag (Davis et al., 1999). As for MBP, several strategies
have been exploited to use the NusA solubility enhancer fusion
partner with puriﬁcation tags and speciﬁc proteases like the
pETM60 vector (EMBL; De Marco et al., 2004) that render the
production of a NusA–His6–TEV fusion protein, or the pET43
(Novagen), that offers the sameNusA–His6 fusionprotein butwith
a thrombin and enterokinase cleavage sites between the fusion tags
and target proteins.
In spite of the different physiochemical and structural proper-
ties, as well as different biological functions, MBP and NusA are
often reported to promote similar solubility improvements in their
target proteins, being ranked as two of the best tags for making
soluble proteins (Shih et al., 2002; Kohl et al., 2008; Bird, 2011).
Both fusion partners were reported to probably work by similar
mechanisms, in which NusA, like MBP, plays a passive role on the
target protein folding (Nallamsetty and Waugh, 2006).
TrxA, or Trx, is a 12-kDa intracellular thermostable protein of
E. coli that is highly soluble expressed in its cytoplasm (Young et al.,
2012). The E. coli Trx can be used for co-production with a tar-
get protein, improving the solubility of the latter (Yasukawa et al.,
1995). Trx is also commonly employed as a fusion tag to avoid
inclusion body’s formation in recombinant protein production by
taking advantage of its intrinsic oxido-reductase activity respon-
sible for the reduction of disulﬁde bonds through thio-disulﬁde
exchange (Stewart et al., 1998; LaVallie et al., 2000; Young et al.,
2012). The fusion partner Trx can be placed both at the N- or
C-terminal of target proteins (LaVallie et al., 2000) but this fusion
partner is more effective at the N-terminal of the target protein
(Terpe, 2003; Dyson et al., 2004). In some HTP screenings (Ham-
marstrom et al., 2002; Dyson et al., 2004; Kim and Lee, 2008), the
Trx fusion partner improves target protein solubility similar to
MBP tag, being considered one of the best choices for protein
production in E. coli.
UnlikeMBP,Trx does not have intrinsic afﬁnity properties, thus
requiring an additional fusion tag for protein puriﬁcation such as
the His6 tag. The pET32 (Novagen), one of the commercially
available vectors for Trx tagging, carries this dual-fusion partners
for protein production and puriﬁcation (Austin, 2003).
Trx fusion partner can also be useful in protein crystallization
of certain target proteins because it readily forms several crystals
itself, and it offers a rigid connection to the target protein, which
is an essential feature for blocking conformational heterogeneity
usually found in various attempts of fusion proteins crystallization
(Smyth et al., 2003; Corsini et al., 2008).
Small ubiquitin related modiﬁer is a small protein (∼11 kDa)
found in yeast (one single gene coding for Smt3) and vertebrates
(three genes coding for SUMO-1, SUMO-2, andSUMO-3; Kawabe
et al., 2000) that has recently been used as an effective N-terminal
solubility enhancer fusion partner, offering advantages over other
fusion systems (Marblestone et al., 2006; Bird, 2011).
The robust SUMO protease (catalytic domains of Ulp1)
offers signiﬁcant advantages over other endoproteases because
it recognizes the tertiary structure of SUMO, and consequently
it does not present unspeciﬁc cleavage of the protein linear
amino acid sequence. Moreover, when used for tag removal,
SUMO protease generates a cleaved target protein with its
native N-terminal amino acid composition (Malakhov et al., 2004;
Marblestone et al., 2006).
Small ubiquitin related modiﬁer promotes the proper folding
and solubility of its target proteins possibly by exerting chaperon-
ing effects in a similarmechanism to the described for its structural
homolog Ubiquitin (Ub; Khorasanizadeh et al., 1996). Ub was
reported to be the nature’s fastest folding protein, and SUMO also
presents a tight, rapidly folding soluble structure (Marblestone
et al., 2006). In addition, Ub and Ub-like proteins (Ulp) have
a highly hydrophobic inner core and a hydrophilic surface that,
togetherwith such a rapid folding,may explain the SUMO’s behav-
ior as a nucleation site for the proper folding of target proteins
(Malakhov et al., 2004; Marblestone et al., 2006).
Small ubiquitin related modiﬁer fusion proteins or peptides are
usually puriﬁed by afﬁnity chromatography using theHis6 tag (Lee
et al., 2008; Gao et al., 2010;Wang et al., 2010; Satakarni andCurtis,
2011). Due to its unique features, SUMO technology has being
constantly explored, and novel strategies for a facile and rapid
protein production are now available, as the SUMO–intein system
(Wang et al., 2012). The SUMO fusion partner is also available for
recombinant protein production in other host cells, namely, insect
cells and other eukaryotic cells (Panavas et al., 2009).
Glutathione-S-transferase fromSchistosoma japonicum (26kDa)
that has been used as an afﬁnity fusion partner for the single-
step puriﬁcation of its target proteins (Smith and Johnson, 1988).
GST can also promote protein soluble production in E. coli, being
more efﬁcient when positioned at the N-terminal rather than at
the C-terminal end (Malhotra, 2009). This fusion partner can
protect its target protein from the proteolytic degradation, sta-
bilizing it into the soluble fraction (Kaplan et al., 1997; Hu et al.,
2008; Young et al., 2012). In spite of performing quite well in
some HTP studies (Dummler et al., 2005; Cabrita et al., 2006; Kim
and Lee, 2008), GST is often a poor solubility tag when com-
pared to other commonly fusion partners, rendering the target
protein production into inclusion bodies (Hammarstrom et al.,
2002; Dyson et al., 2004; Hammarstrom, 2006; Kohl et al., 2008;
Ohana et al., 2009).
Glutathione transferases are dimeric enzymes that catalyze the
nucleophilic addition of the thiol of glutathione to a wide range
of hydrophobic electrophilic molecules (Ketterer, 2001). Taking
this feature into account, GST can be useful for monitoring the
protein production and puriﬁcation via its catalytic activity, and
the puriﬁcation of GST fusion proteins can be easily performed by
afﬁnity chromatography using glutathione derivates immobilized
into a solid support (Viljanen et al., 2008). GST fusion proteins
can be eluted with glutathione under mild conditions (Vinckier
et al., 2011).
A major disadvantage for using GST as solubility and afﬁn-
ity tag relies on its oligomerized form: GST has four solvent
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exposed cysteines that can provide a signiﬁcant oxidative aggre-
gation (Kaplan et al., 1997), making it a poor choice for tagging
oligomeric target proteins (Malhotra, 2009).
As occurs with MBP, GST can be coupled with other afﬁnity
strategies, for instance, the His6 tag, to improve the protein puriﬁ-
cation (Scheich et al., 2003; Hayashi and Kojima, 2008; Hu et al.,
2008). GST expression vectors like the pGEX (Hakes and Dixon,
1992) or pCold-GST (Hayashi and Kojima, 2008) usually contain
a protease recognition site between the fusion tag coding gene and
the target protein coding gene forGST tag’s removal after or during
protein puriﬁcation.
GST has also been applied as a fusion partner in other expres-
sion systems apart from the E. coli such as yeast (Mitchell et al.,
1993), insect cells (Beekman et al., 1994), and mammalian cells
(Rudert et al., 1996). This fusion partner has shown to be useful
for protein labeling (Ron and Dressler, 1992; Viljanen et al., 2008),
antibody production (Aatsinki and Rajaniemi, 2005), and vaccine
development (Mctigue et al., 1995).
In addition to these commonly used fusion partners, new sol-
ubility enhancer tags are constantly emerging in literature (see the
corresponding references in Table 1), as for instance, the Fh8 tag
[see The Novel Fh8 Fusion System (Hitag®)], HaloTag, which uses
a modiﬁed haloalkane dehalogenase protein that improves protein
solubility and can bind to several synthetic ligands, themonomeric
mutant of Orc protein of the bacteriophage T7 (Mocr), the E. coli
protein Skp, stress-responsive proteins RpoA, SlyD, Tsf, RpoS, part
of the domain I of IF2 (expressivity tag), the E. coli secreted pro-
teinA (EspA), and the SNUT tag, which is a protein derived from a
portion of the bacterial transpeptidase sortase A of Staphylococcus
aureus.
Afﬁnity puriﬁcation handles
Afﬁnity fusion partners have widely contributed for the develop-
ment of recombinant protein production studies in basic research
and in HTP structural biology (Waugh, 2011) by simplifying pro-
tein puriﬁcation procedures, and allowing for protein detection,
and characterization (Butt et al., 2005; Malhotra, 2009; Young
et al., 2012).
Afﬁnity puriﬁcation handles can be divided into two groups:
(1) peptides or proteins that bind a small ligand immobilized on
a solid support, as for instance, the His6 tag and nickel afﬁnity
resins, and (2) tags that bind to an immobilized molecule such as
antibodies (Arnau et al., 2006).
The puriﬁcation of a target protein using an afﬁnity handle
offers several advantages over the conventional chromatographic
methodologies, namely:
(i) The target protein never interacts directly with the chromato-
graphic resin (Waugh, 2005);
(ii) Target proteins can be easily obtained pure after a single-step
puriﬁcation (Terpe, 2003);
(iii) Afﬁnity puriﬁcation offers a variety of strategies to bind the
target protein on an afﬁnity matrix (Malhotra, 2009);
(iv) Afﬁnity tags are an economically favorable and time-saving
strategy, and they allowdifferent proteins tobepuriﬁedusing a
common method in contrast to highly customized procedures
used in conventional chromatographic puriﬁcation (Arnau
et al., 2006).
An afﬁnity tag is often chosen taking into account the puriﬁca-
tion costs: different afﬁnity media and elution principles present
different expenses during the operation process and should there-
fore be carefully selected at the beginning of the cloning strategy.
The buffer requirements are also essential for the designing of an
efﬁcient puriﬁcation strategy (Malhotra, 2009). In addition, the
choice of an afﬁnity can also rely on the size: small tags are useful
for protein detection and antibody production, as they are not
immunogenic as large tags (Terpe, 2003).
Tandem afﬁnity puriﬁcation (TAP) or dual-tagging strategies
are now commonly used in recombinant protein production: they
offer a highly speciﬁc isolation of target proteins with minimal
background and under mild conditions, and they are very useful
in the study of protein interactions, allowing the separation of
different mixed protein complexes (Arnau et al., 2006; Li, 2010).
Table 2 lists some of the common and novel puriﬁcation tags
used in recombinant protein production.
The polyhistidine afﬁnity tag or His tag consists of a variable
number of consecutive histidine residues (usually six) that coordi-
nate, via the histidine imidazole ring, transition metal ions such as
Ni2+ or Co2+ immobilized on beads or a resin for IMAC (Gaberc-
Porekar and Menart, 2001; Terpe, 2003; Kimple and Sondek, 2004;
Malhotra, 2009). Commonly used IMAC resins such as nitrilotri-
acetic acid agarose (Ni–NTA, from Qiagen), or carboxymethylas-
parte agarose (Talon, fromClonTech) have a high binding capacity,
and can be used for puriﬁcation of fusion proteins directly from
crude cell lysates (Terpe, 2003; Kimple and Sondek,2004; Li, 2010).
TheHis tag is one of themost widely used puriﬁcation tags, and
it offers several advantages (Kimple and Sondek, 2004; Li, 2010):
(i) Its small size and charge rarely interferes with protein function
and structure;
(ii) It can be used under native and denaturing conditions
(iii) Target proteins can be eluted under mild conditions by
imidazole competition or low pH.
The His tag has been used in several HTP screenings, placed
at the N- or C-terminal end, or even in the middle of the fusion
protein (Cabrita et al., 2006; Hammarstrom, 2006; Marblestone
et al., 2006; Bird, 2011), and it is also an useful tool in protein
crystallization as well as protein detection (Carson et al., 2003;
Kimple and Sondek, 2004).
Taking into account the mechanism of protein interaction with
the immobilized ions, careful should be taken in IMAC to avoid
strong reducing and chelating agents in any of the buffers (as
for instance, EDTA), as they will reduce or strip the immobi-
lized metal ions (Carson et al., 2003; Kimple and Sondek, 2004;
Li, 2010).
Epitope tags are short sequences of amino acids that serve as the
antigen region to which the antibody binds, being suitable for sev-
eral immunoapplications. These include afﬁnity chromatography
on immobilized monoclonal antibodies, and protein trafﬁcking
in vitro or in cell cultures (Kimple and Sondek, 2004; Young et al.,
2012). Epitope tagging engages an expensivepuriﬁcation that often
limits its wide application.
The following partners are often used as epitope tags: the FLAG
tag (Einhauer and Jungbauer, 2001), the hemaglutinin, and the c-
Myc (Fritze and Anderson, 2000). Their short sequences rarely
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Table 2 | Affinity purification tags [adapted from Esposito and Chatterjee (2006), Malhotra (2009)].
Tag Protein Size (aa) Affinity matrix Elution Reference
His6 Hexahistidine tag 6–10 Immobilized metal ion – Ni, Co,
Cu, Zn
Competition with imidazole Gaberc-Porekar and Menart
(2001)
Fh8 Fasciola hepatica 8-kDa
antigen
69 Hydrophobic (calcium
dependent interaction)
Ca2+-chelating agents such as
EDTA or pH manipulation
Costa (2013), Costa et al. (2013b)
GST Glutathione-
S-transferase
211 Glutathione Competition with free
glutathione
Smith and Johnson (1988)
MBP Maltose-binding protein 396 Amylose Competition with maltose di Guan et al. (1988), Pryor and
Leiting (1997)
FLAG FLAg tag peptide 8 Anti-FLAG antibody octapeptide
when using anti-FLAG M2
antibody
Competition with FLAG Einhauer and Jungbauer (2001)
Strep-II Streptavidin binding
peptide
8 Streptavidin Competition with biotin and
derivatives
Schmidt and Skerra (1994)
CBP Calmodulin-binding
protein
26 Immobilized calmodulin Ca2+-chelating agents Vaillancourt et al. (2000)
HaloTag Mutated dehalogenase ∼300 Chloroalkane Covalent binding and proteolytic
release of target protein
Ohana et al. (2009)
Protein A Staphylococcal Protein A 280 Immobilized IgG pH manipulation (acidic) Stahl and Nygren (1997)
IMPACT (CBD) Intein mediated
puriﬁcation with the
chitin-binding domain
51 Chitin Intein self-cleavage induction
with dithiothreitol,
β-mercaptoethanol or cysteine
Chong et al. (1997), Sheibani
(1999)
CBM Cellulose-binding module * Cellulose Urea and guanidine–HCl or
ethylene glycol
Tomme et al. (1998), Ramos
et al. (2010), Ramos et al. (2013)
Dock Dockerin domain of
Clostridium josui
22 Cohesin – Cellulose Ca2+-chelating agents Kamezaki et al. (2010)
Tamavidin fungal avidin-like protein ∼140 Biotin Free biotin in excess when
using theTamavidin 2-REV tag
Takakura et al. (2010, 2013)
*Several sizes, from 4 to 20 kDa.
interfere with structure or function of target proteins, and are very
speciﬁc for their respective primary antibodies (Kimple and Son-
dek, 2004; Malhotra, 2009). The FLAG tag is a short hydrophilic
eight amino-acid peptide, and it was the ﬁrst tag to be used
in the epitope context. This tag works either for protein detec-
tion or puriﬁcation (Hopp et al., 1988; Knappik and Pluckthun,
1994), and it has an intrinsic enterokinase cleavage site at its
C-terminus end, allowing its complete removal from the target
protein (Einhauer and Jungbauer, 2001; Young et al., 2012).
Strep II tag is a short tag of only eight amino acid residues that
possesses a strong and speciﬁc binding to streptavidin via its biotin
pocket (Schmidt and Skerra, 1994). This afﬁnity partner can be
fused at both N- or C-terminal ends, or within the target protein.
Strep II-fusedproteins elute fromstreptavidin columnswith biotin
derivates under gentle conditions (Terpe, 2003; Li, 2010).
The CBP tag is a calmodulin-binding peptide derived from the
C-terminus of skeletal muscle myosin light chain kinase, and it
has been used as an N- or C-terminal afﬁnity tag of target protein
puriﬁcation on a calmodulin immobilized matrix (Terpe, 2003;
Malhotra, 2009). TheCBP interactionwith calmodulin is calcium-
dependent, and hence, the addition of calcium-chelating allows
the single step elution of target proteins under gentle conditions
(Terpe, 2003; Malhotra, 2009; Li, 2010). This tag is an afﬁnity
system highly speciﬁc for protein puriﬁcation in E. coli but not
in eukaryotic systems, as E. coli does not contain endogenous
proteins that interact with calmodulin (Terpe, 2003; Malhotra,
2009).
In addition to the above-mentioned afﬁnity tags, new afﬁnity
puriﬁcation strategies are now described in literature for pro-
tein isolation and detection (see the corresponding references in
Table 2) such as the Fh8 tag [see The Novel Fh8 Fusion Sys-
tem (Hitag®)], cellulose-binding domains I, II, and III (CBD),
the HaloTag, the dockerin domain Dock tag, and the avidin-like
protein, Tamavidin tag.
Tag removal
The removal of the fusion partner from the ﬁnal protein is often
necessary because the tag can potentially interfere with the proper
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structure and functioning of the target protein (Waugh, 2005;
Malhotra, 2009; Young et al., 2012).
Fusion partners are removed from their target proteins either
by enzymatic cleavage, in which site speciﬁc proteases are
used under mild conditions, or by chemical cleavage, like for
instance formic acid (Ramos et al., 2010, 2013), that offers a
less expensive tag removal but it is also less speciﬁc compared
to the enzymatic strategy, besides presenting harsh conditions
that can affect the target protein stability and solubility (Mal-
hotra, 2009; Li, 2011). Fusion partners can also be cleaved
from the target protein using an in vivo cleavage strategy, in
which a controlled intracellular processing (CIP) is applied as
follows: the fusion protein and protease are produced from
separate compatible expression vectors that can be regulated
independently of one another. The protease cleaves the fusion
protein in vivo, offering the advantage of not compromising
the target protein’s purity level or its production yields like
often occurs in in vitro cleavage strategies (Kapust and Waugh,
2000).
The efﬁciency of the enzymatic removal of fusion proteins may
vary in an unpredicted manner with different proteins (Li, 2011;
Vergis and Wiener, 2011; Young et al., 2012), and it often requires
the optimization of cleavage conditions through a trial-and-error
process (Malhotra, 2009). Two types of proteases can be used for
tag removal (reviewed in Waugh, 2011):
(i) Endoproteases: they are divided into serine proteases such as the
activated blood coagulation factor X (factor Xa), enterokinase,
and α-thrombin, and viral proteases like the tobacco etch virus
(TEV), and the human rhinovirus 3C protease (Table 3). In
spite of recognizing a similar number of substrate amino acid
residues, viral proteases have usually more stringent sequence
speciﬁcity than serine proteases, presenting also slower rates
than the latter. Endoproteases are useful tools for the removal
of N-terminal fusion tags, since they cleave close to the C-
terminus end of their recognition sites thus leaving the target
protein with its native N-terminal sequence.
(ii) Exoproteases: they are often used together with endopro-
teases mainly for the removal of C-terminal fusion tags. The
available exoproteases include metallocarboxypeptidases, and
aminopeptidases.
The removal of a fusion tag is usually accomplished by two
puriﬁcation steps, as follows: after the initial afﬁnity puriﬁcation
step (e.g., via a histidine tag located at the N-terminal of the fusion
protein), the puriﬁed fusion protein is mixed in solution with the
endoprotease (e.g., a his-tagged protease) to cleave off the tag.
The cleaved target protein is recovered in the ﬂow-through sam-
ple after a second afﬁnity puriﬁcation step, in which the cleaved
fusion tag and the added protease are collected in the eluted
sample.
In spite of widely employed, the removal of fusion partners has
always been theAchilles’ heel of afﬁnity tagging, presenting several
difﬁculties such as:
(i) Unspeciﬁc cleavage due to the recognition of a linear amino
acid sequence (except for SUMO protease);
(ii ) Inefﬁcient processing due to steric hindrance or the presence
of unfavorable residues around the cleavage site (Li, 2011;
Waugh, 2011). The inclusion of extra amino acid residues (a
spacer or linker) between the cleavage site and target protein
(Esposito and Chatterjee, 2006; Malhotra, 2009) can alleviate
this problem;
(iii) Low protein yields after tag removal, and failure in recover
active, structurally organized target proteins due to protein
precipitation and aggregation (Butt et al., 2005;Waugh, 2011);
(iv) High costs of proteases and tedious optimization of cleavage
conditions (Smyth et al., 2003).
Independently of the cleavage type, additional chromato-
graphic steps are often required to purify the target protein from
the cleavage mixture. Although conventional afﬁnity technologies
have greatly simpliﬁed recombinant protein production, resins,
and buffers are still too expensive. Hence, the tag removal adds
another layer of complexity and expense to the recombinant
protein production process (Mee et al., 2008; Li, 2011).
Self-cleaving tags are a special group of fusion tags that pos-
sess inducible proteolytic activity, therefore being considered an
attractive alternative to the existent afﬁnity strategies for simple
and costless protein puriﬁcation and tag removal (Chong et al.,
1997; Li, 2011).
The protein splicing is a process in which the intervening
sequence (intein) removes itself and binds the ﬂaking residues
(exteins) to produce two independent protein products (Perler
Table 3 | Common endoproteases for tag removal [adapted from Malhotra (2009)].
Protease Source Cleavage site Reference
TEV Tobacco etch virus protease ENLYFQ/G Parks et al. (1994), Kapust et al. (2001)
EntK Enterokinase DDDDK/ Choi et al. (2001)
Xa Factor Xa IEGR/ Jenny et al. (2003)
Thr Thrombin LVPR/GS Jenny et al. (2003)
PreScission Genetically engineered derivative of
human rhinovirus 3C protease
LEVLFQ/GP Cordingley et al. (1990),
GE Healthcare (2010)
SUMO protease Catalytic core of Ulp1 Recognizes SUMO tertiary structure and cleaves
at the C-terminal end of the conserved Gly–Gly
sequence in SUMO
Malakhov et al. (2004), Butt et al.
(2005), Marblestone et al. (2006)
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et al., 1994). Self-cleaving tags undergo speciﬁc cleavage upon
being triggered by low molecular weight compounds or upon
a change of conformation. The available technologies include
inteins, the S. aureus sortase A, the N-terminal protease (Npro),
the Neisseria meningitides iron-regulated protein FrpC, and the
cysteine protease domain secreted by Vibrio cholerae, all of them
reviewed in Li (2011).
THE NOVEL Fh8 FUSION SYSTEM (Hitag®)
Fh8 (GenBank ID:AF213970.1) is one of the promising new fusion
technologies, advancing the existing tags by acting simultaneously
as an effective solubility enhancer partner (Costa et al., 2013a)
and robust puriﬁcation handle (Costa et al., 2013b). Actually, the
Fh8 is one of the few existent fusion tags to offer this combined
feature of enhancing protein solubility and puriﬁcation, and its
low molecular weight (8 kDa) is also a great advantage over other
large fusion partners for recombinant protein production in E. coli
(Costa, 2013).
The Fh8 is a small antigen (8 kDa) excreted-secreted by the par-
asite F. hepatica in the early stages of infection (Silva et al., 2004).
This protein is located on the surface of the parasite, and it was
suggested as auseful tool for thediagnosis, vaccine, anddrugdevel-
opment against F. hepatica infections (Silva et al., 2004). The use
of recombinant Fh8 produced in E. coli led to the development of
a novel, rapid, and simple immunodetection of F. hepatica infec-
tions (Silva et al., 2004). Moreover, when produced recombinantly
in E. coli, the Fh8 revealed to be a highly soluble and unusual
thermal stable protein (keeping secondary structure integrity up
to 74◦C; Silva et al., 2004; Fraga et al., 2010).
The Fh8 has high homology with 8-kDa calcium-binding pro-
teins (CaBPs) of Schistosoma mansoni (Sm8; Ram et al., 1989), of
Clonorchis sinensis (Ch8), and of S. japonicum (Sj8; Lv et al., 2009),
and it belongs to the calmodulin-like EF-hand CaBP family (Fraga
et al., 2010).
CaBPs are structurally organized by EF-hand motifs, which are
helix–loop–helix structures that participate in Ca2+ coordination
(Bhattacharya et al., 2004; Zhou et al., 2006; Chazin, 2011). Upon
calciumbinding,Ca2+sensor proteins, like calmodulin (Nelson and
Chazin, 1998; Chin and Means, 2000) and troponin C (Nelson and
Chazin, 1998), translate the physiological changes in calcium lev-
els by undergoing a conformational change. This then allows the
binding of other proteins downstream the process. In EF-hand
proteins, the open of the EF-hand structure exposes a hydropho-
bic surface, which binds the target sequence (Lewit-Bentley and
Rety, 2000; Bhattacharya et al., 2004). Ca2+ buffer proteins, such as
calbindin D9k and parvalbumin (Schwaller, 2010), are involved in
calcium signal modulation, undergoing minimal conformational
changes upon calcium binding.
The Fh8 presents two EF-hand motifs, and it was characterized
as a Ca2+sensor protein: when calcium binds, the Fh8 switches
from a closed (apo-state) to an open (calcium-loaded state) con-
formation due to the reorientation of the four helices, exposing
a large hydrophobic region that acts as a target-binding surface
(Fraga et al., 2010).
Previous studies for the prediction of the Fh8 three-
dimensional structure (unpublished data) showed that almost
all the Fh8’s amino acid sequence is involved or affected by the
calcium-binding, with the exception of small residue sequences
in the N-terminal (11 amino acid residues) and C-terminal (six
amino acid residues). Considering that theN-terminal of a protein
is very important for its half-life, the ﬁrstN-terminal 11 residues of
Fh8 were named the “H sequence” and were initially suggested to
play a key role in the stability and production of the entire Fh8 pro-
tein. This H sequence could also be critical for the immunological
response of the Fh8 antigen.
Taking into account the Fh8 high solubility and stability when
expressed in E. coli together with its calcium-binding properties,
and given the potential importance of the H sequence, both Fh8
and H peptides were suggested to function as fusion tags for pro-
tein production and solubility in E. coli, protein puriﬁcation, and
antibody production.
The application of both Fh8 (8 kDa) and H (1 kDa) pep-
tides as fusion tags for protein overproduction in E. coli was
ﬁrst reported by Conceição and co-workers, using the following
recombinant proteins: a 12-kDa surface protein of Cryptosporid-
ium parvum (CP12), the interleukin-5 of human origin (IL-5),
and an oocyst wall protein of Toxoplasma gondii (TgOWP;
Conceição et al., 2010). This initial study showed that both Fh8
and H peptides have indeed a positive effect on the E. coli produc-
tion levels of all target proteins, reaching values three- to 16-fold
higher than those obtained with non-fused target proteins.
The Fh8 and H fusion tags were then studied as solubility
enhancer tags, and their performance was compared with other
commonly used fusion tags available in the Protein Expression
and Puriﬁcation Core Facility of the European Molecular Biology
Laboratory (Costa, 2013; Costa et al., 2013a). Figure 2 illustrates
the schematic pathway from protein production to puriﬁcation
with the studied solubility tags (His6 tag, GST, MBP, NusA, Trx,
SUMO, H, and Fh8). Here, the selected target proteins included
the 12-kDa surface protein of C. parvum (CP12), the lectin frutalin
from theArtocarpus incisa plant (FTL;Oliveira et al., 2008,2009a,b,
2011), and four proteins from the yeast S. cerevisiae: reduced via-
bility upon starvation protein 167 (RVS167), phospholipase D1
(SPO14), and serine/threonine-protein kinases 1 and 2 (YPK1 and
YPK2). These target proteinswere all known as difﬁcult-to-express
inE. coli, and presented differentmolecular weights, locations, and
functions. The evaluation of their solubility and consequent effect
of each fusion tag was performed after nickel afﬁnity puriﬁcation
and upon tag removal in 10-mL cultures and in 500-mL cultures.
This comparison study showed that the Fh8 fusion partner
stands among the well-described best fusion partners,MBP,NusA,
and Trx, for soluble protein production. For the proteins tested,
both GST and H fusion tags did not improve target protein
solubility in E. coli.
The novel Fh8 fusion partner is thus an excellent candidate for
testing production and solubility next to the other well-known
fusion tags. Its low molecular weight and its solubility enhancing
effectmake Fh8 an advantageous option compared to larger fusion
tags for soluble protein production in E. coli.
Apart from its solubility enhancer effect, the Fh8 was also
explored by Costa (2013), Costa et al. (2013b) as a puriﬁcation
handle via its calcium-binding behavior combined with HIC. Two
different model proteins were used within this study: green ﬂuo-
rescent protein (GFP) and superoxide dismutase (SOD), and the
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FIGURE 2 | Schematic pathway from protein production to purification
using the solubility tags and the hexahistidine (His6) affinity tag of the
comparison conducted by Costa et al. (2013a; adapted from Esposito and
Chatterjee, 2006). (A) Eight tagged versions of theTP were expressed in E.
coli : some fusions can end-up in the insoluble fraction whereas others remain
in the soluble fraction. (B) Soluble fusion proteins are then puriﬁed by
immobilized metal afﬁnity chromatography (IMAC) using the His6 tag and the
fusion tags are removed from theTP by protease cleavage. (C) Some fusions
will not cleave efﬁciently, resulting in a mixture of cleaved and uncleaved
proteins that are difﬁcult to separate. (D) Other fusions will cleave efﬁciently,
and theTP remain in solution, being collected in the ﬂow-through sample of a
second IMAC puriﬁcation step (as occurred with the Fh8 tag). Despite a
successful protease cleavage, someTPs can become insoluble after tag
removal leading to protein precipitation.
Fh8-HIC performance was also compared to the one of His tag
technology (via IMAC).
Figure 3 resumes the puriﬁcation mechanism of target pro-
teins using the Fh8-HIC strategy. As previously mentioned, the
Fh8 is a Ca2+-sensor protein that opens its structure upon cal-
cium accommodation. The opening of the Fh8’s structure exposes
a large hydrophobic surface that becomes available for interaction
with its targets (Fraga et al., 2010). In this study, the Fh8 tag
and Fh8-fused proteins presented a calcium-dependent inter-
action with a hydrophobic resin, and, as reported for other
calcium-binding proteins (Rozanas, 1998; Shimizu et al., 2003),
this interaction was still occurring even with low salt concentra-
tion in the mobile phase. The low salt concentration decreases
the unspeciﬁc binding of other proteins from the E. coli extracts,
thus promoting selectivity toward the puriﬁcation of the fusion
protein of interest (Costa et al., 2013b). Moreover, it was also
shown that, as a calcium-binding protein, the Fh8 tag and Fh8-
fused proteins can be eluted by using a calcium chelating agent,
such as EDTA. One can also use for elution a mobile phase
with an increased pH (e.g., pH 10), which creates a net charge
that destabilizes hydrophobic interactions. This elution strat-
egy allows a single-step and rapid elution of all bound proteins
(Costa et al., 2013b).
The Fh8-HIC methodology presented also the advantage of
being compatible with the IMAC technique, thus, allowing a
dual protein puriﬁcation strategy that can be used sequentially,
complementing each other, to obtain an active and more puriﬁed
protein when desired. In addition, the use of two consecutive
puriﬁcation steps and the distinct nature of HIC and IMAC
methodologies is known to help for the efﬁcient removal of
contaminating proteins (McCluskey et al., 2007).
Regarding the H tag, it did not function as a solubility enhancer
tag, but it improved the production levels of target proteins in
E. coli similarly to the Fh8 tag (Costa et al., 2013a). Taking that
into account, the H tag was further explored for the recombinant
production of antigens of interest in E. coli, and their subsequent
immunization and polyclonal antibody production.
The major novelty of the H tag relies on its small size (1 kDa)
combined with the adjuvant-free immunization of antigens
(Conceição et al., 2011; Costa, 2013; Costa et al., 2013c). Figure 4
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FIGURE 3 | Protein purification strategy using the Fh8-HIC
methodology. (A) Binding step: the Fh8-fused protein interacts with the
hydrophobic matrix in the presence of calcium and at low salt
concentration. This initial binding condition decreases the unspeciﬁc
binding of other proteins from the E. coli extracts, which leave the column
in the ﬂow-through sample. (B)Washing step: by lowering the salts and
calcium concentration, weakly interacting contaminant proteins are
washed-out, and the Fh8-fused protein remains attached to the
hydrophobic matrix. (C) Elution step: a calcium chelating agent, as for
instance EDTA, will interfere in the calcium-dependent binding of the
Fh8-fused protein, resulting in its elution from the hydrophobic matrix. The
Fh8-fused protein can also be eluted by an alternative method: increasing
the pH of the elution buffer to 10. This rise in the pH will promote a net
charge around the fusion protein, which destabilizes the hydrophobic
interactions and results in the elution of the fusion protein.
shows the schematic pathway of using the H fusion tag from gene
to antibody.
Costa et al. (2013c) showed a successful case study with the
CP12 antigen, which has a low molecular weight that can hinder
the production of polyclonal antibodies. The HCP12 fusion anti-
gen elicited an earlier immune response andhigher (approximately
2-fold) polyclonal antibody titers than the non-fused CP12
(Conceição et al., 2011; Costa et al., 2013c). This application study
demonstrated that the H partner improves the speciﬁc polyclonal
antibody production against theCP12 antigenwithout using adju-
vants, and the resulting polyclonal antibodies can be used as a
diagnostic tool for immunodetection of C. parvum infections in
humans or animals (Costa et al., 2013c).
Apart from CP12, several H-fused antigens have already been
produced in E. coli (Conceição et al., 2010) and immunized
FIGURE 4 |The schematic pathway from gene to antibody using the
H fusion tag (Costa et al., 2013c). (A) Production of H-fused antigens in E.
coli : *the antigen-codifying gene is inserted into a H-tag expression vector,
and protein production and puriﬁcation are optimized following the
conditions presented in Figure 1. (B) E. coli endotoxins can be removed
using a commercial endotoxin-removal kit or by hydrophobic interaction
chromatography. (C) Puriﬁed H-fused antigens can be administrated into
mice, rabbits, goats, among others, and this procedure is conducted
without adjuvants. (D)The produced sera are analyzed by enzyme-linked
immunosorbent assay (ELISA),Western blot, immunoﬂuorescence assay
(IFA), among others, to validate the speciﬁcity and practical application of
polyclonal antibodies. Further processing may be required in order to obtain
highly puriﬁed polyclonal antibodies.
in mice and rabbits, such as, the human interleukin-5 (IL-
5), the cyst wall protein-1 from T. gondii (TgOWP), the cyst
wall protein from Giardia lamblia cysts (CWG), the β-giardin
cytoskeletal protein of the ventral disk from theG. lamblia tropho-
zoite (βG), the cyst wall speciﬁc-glycoprotein Jacob from Enta-
moeba histolytica (Ent), and the falcipain-1 trophozoite cysteine
proteinase from Plasmodium falciparum (Pfsp), among others
(Conceição et al., 2011).
CONCLUSIONS AND FUTURE TRENDS
The growing demand for effective health and environmental
biotechnology resources has advancing the design of different
strategies for the successful protein production in E. coli. Its
Frontiers in Microbiology | Microbiotechnology, Ecotoxicology and Bioremediation February 2014 | Volume 5 | Article 63 | 14
Costa et al. Fusion tags for protein production
beneﬁts of cost and ease of use and scale make E. coli one
of the most widely used host systems for recombinant protein
production, but one must be aware that success is not always guar-
anteed in this prokaryotic host system, mainly when working with
recombinant proteins of human origin.
This reviewhighlighted several key factors that contribute to the
soluble proteinproduction andpuriﬁcation inE. coli, including the
use of differentmutated host strains, co-production of chaperones
and foldases and testing different cultivation conditions, with a
main focus in the gene fusion technology.
The use of fusion partners was an important turning point for
the E. coli host system: fusion tags promote or increase protein
solubility, help on protein puriﬁcation and can also be used to
increase protein’s immunogenicity. Traditional fusion systems like
MBP,GST,NusA,or Trx have constantly been challenged and com-
plemented by novel fusion solutions such as the SUMO tag (Butt
et al., 2005; Marblestone et al., 2006), the HaloTag (Ohana et al.,
2009), the SNUT tag (Caswell et al., 2010), and the expressivity tag
(Hansted et al., 2011), among others.
More recently, a novel and unique fusion system for simple and
inexpensive soluble protein overproduction and puriﬁcation in E.
coli was developed and studied: the Fh8 tag (Costa, 2013).
The Fh8 is ranked among the best solubility enhancer tags as
Trx, MBP, or NusA (Costa et al., 2013a), and it offers a speciﬁc
and simple puriﬁcation of the target proteins by using its natural
calcium-binding properties and mild conditions for HIC (Costa
et al., 2013b). The Fh8 fusion partner is one of the few existing
tags to promote simultaneously target protein solubility directly
into the E. coli cytoplasm and a simple and cost-effective protein
puriﬁcation.
The novel Fh8 fusion system overcomes several issues related
with recombinant protein production in E. coli: by using a
straightforward methodology, this novel system increases protein
production levels, promotes protein solubility and low cost puriﬁ-
cation, and helps for protein immunogenicity, in which the H tag
facilitates a simple, rapid, and adjuvant-free production from gene
to antibody (Costa et al., 2013c). This novel fusion system offers
the great advantage of combining these four abilities into the two
lowest molecular weight fusion partners described so far. Hence,
the Fh8 fusion system appears as a valuable tool for the efﬁcient
and economical recombinant protein production in E. coli.
While this review applies to the use of Fh8 and H tags for
recombinant protein production in bacterial host systems, it is
hoped that the novel fusion system presented here will apply to
other hosts, as for instance, eukaryotes and mammalian cells and
thus, this must be investigated.
Despite being widely employed to improve soluble protein pro-
duction in E. coli, fusion tags are not yet well comprehended as
suggested by the general lack in literature of studies regarding
their mechanism of action. Therefore, efforts should be taken to
disclose how fusion tags work while promoting such a positive
effect in the protein production in E. coli. Perhaps, a wide sys-
tems biology analysis can help to reveal the different pathways that
fusion tags undergo in E. coli, leading also to their organization
into functional groups.
Taking into account the broad range of applications, the trend
is that the number of available fusion tags will increase, and the
understanding of their way of action will, undoubtedly, allow the
development of tailored-made tools for protein production.
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